Abdul Rehman Azam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abdul Rehman Azam has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Fahad Amin
King Edward Medical University, Lahore, Pakistan
2 shared publications - Hurain Naeem
King Edward Medical University, Lahore, Pakistan
2 shared publications - Taimoor Hassan
King Edward Medical University, Lahore, Pakistan
2 shared publications - Abdul Sami Ur Rehman Ghani
King Edward Medical University, Lahore, Pakistan
1 shared publication - Ammad Abid
King Edward Medical University, Neela Gumbad, Lahore, Pakistan
1 shared publication - Arbab Khalid
Kirk Kerkorian School of Medicine at UNLV, Las Vegas, USA
1 shared publication
Latest Publications
- 10 July 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (8)
Therapeutic equivalence of intermittent and continuous phototherapy for neonatal jaundice: a systematic review & meta-analysis with regression and trial sequential analysis
Phototherapy is the mainstay treatment for neonatal hyperbilirubinemia, but the optimal delivery strategy remains debated. Intermittent phototherapy (IMPT) has been proposed as an alternative to continuous phototherapy (CPT) that may achieve comparable bilirubin reduction with fewer adverse effects. This systematic review and meta-analysis evaluated the comparative efficacy and safety of IMPT versus CPT in neonates with hyperbilirubinemia. PubMed, Embase, Scopus, Cochrane Library, and ClinicalTrials.gov were searched through June 2026 for randomized controlled trials comparing IMPT and CPT. Outcomes included rate of fall in bilirubin, follow-up bilirubin, phototherapy duration, hospital stay, and mortality. Random-effects meta-analysis pooled mean differences (MD) and risk ratios (RR) with 95% confidence intervals (CI). Subgroup, meta-regression, and Trial Sequential Analysis (TSA) were performed, and certainty of evidence was graded using GRADE. Twenty-six RCTs (3,891 neonates) were included. No significant difference was found between IMPT and CPT for rate of bilirubin fall, follow-up bilirubin, hospital stay, or mortality. IMPT significantly reduced phototherapy duration (MD - 10.40 h, 95% CI - 18.91 to - 1.88). Heterogeneity was substantial across outcomes. TSA indicated conclusive evidence of equivalence for bilirubin-related and hospital stay outcomes, while evidence for the duration reduction had not yet reached the required information size. Certainty of evidence ranged from low to very low. IMPT achieves outcomes comparable to CPT while significantly reducing treatment duration, supporting its use as a time-efficient alternative, though findings warrant cautious interpretation given low certainty of evidence. • IMPT and CPT show comparable bilirubin reduction, but prior comparisons relied on limited trials without assessing whether the evidence base is conclusive. • This review incorporates the latest trials, applies Cochrane-guided meta-regression, subgroup, leave-one-out, and Hartung-Knapp sensitivity analyses, and uses TSA to confirm conclusive equivalence across major outcomes.
- 10 July 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (8)
Therapeutic equivalence of intermittent and continuous phototherapy for neonatal jaundice: a systematic review & meta-analysis with regression and trial sequential analysis
Phototherapy is the mainstay treatment for neonatal hyperbilirubinemia, but the optimal delivery strategy remains debated. Intermittent phototherapy (IMPT) has been proposed as an alternative to continuous phototherapy (CPT) that may achieve comparable bilirubin reduction with fewer adverse effects. This systematic review and meta-analysis evaluated the comparative efficacy and safety of IMPT versus CPT in neonates with hyperbilirubinemia. PubMed, Embase, Scopus, Cochrane Library, and ClinicalTrials.gov were searched through June 2026 for randomized controlled trials comparing IMPT and CPT. Outcomes included rate of fall in bilirubin, follow-up bilirubin, phototherapy duration, hospital stay, and mortality. Random-effects meta-analysis pooled mean differences (MD) and risk ratios (RR) with 95% confidence intervals (CI). Subgroup, meta-regression, and Trial Sequential Analysis (TSA) were performed, and certainty of evidence was graded using GRADE. Twenty-six RCTs (3,891 neonates) were included. No significant difference was found between IMPT and CPT for rate of bilirubin fall, follow-up bilirubin, hospital stay, or mortality. IMPT significantly reduced phototherapy duration (MD - 10.40 h, 95% CI - 18.91 to - 1.88). Heterogeneity was substantial across outcomes. TSA indicated conclusive evidence of equivalence for bilirubin-related and hospital stay outcomes, while evidence for the duration reduction had not yet reached the required information size. Certainty of evidence ranged from low to very low. IMPT achieves outcomes comparable to CPT while significantly reducing treatment duration, supporting its use as a time-efficient alternative, though findings warrant cautious interpretation given low certainty of evidence. • IMPT and CPT show comparable bilirubin reduction, but prior comparisons relied on limited trials without assessing whether the evidence base is conclusive. • This review incorporates the latest trials, applies Cochrane-guided meta-regression, subgroup, leave-one-out, and Hartung-Knapp sensitivity analyses, and uses TSA to confirm conclusive equivalence across major outcomes.
- 25 February 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 287
Robot-Assisted Versus Standard Laparoscopic Radical Nephrectomy for Renal Tumors: An Updated Systematic Review And Meta-Analysis with Meta-Regression
- 25 February 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 287
Robot-Assisted Versus Standard Laparoscopic Radical Nephrectomy for Renal Tumors: An Updated Systematic Review And Meta-Analysis with Meta-Regression
- 28 April 2025
- Published by Springer Nature in Biological Trace Element Research
- Vol. 203 (12) , 6206-6212
Is There Any Role of Zinc and Copper in Severity and Progression of Osteoarthritis? A Review
Osteoarthritis (OA) is one of the most prevalent chronic diseases of the aging population, with an incidence of more than 250 million affected people and annual treatment costs exceeding $80 billion. Osteoarthritis involves pain, stiffness, reduced mobility, and swelling of the joints due to cartilage wear and tear and inflammation, which results in a broad system affecting the joints. This review focuses on the relationship between zinc and copper and the effects of these minerals on osteoarthritis. Osteoarthritis is a degenerative disease that currently affects millions of people and is characterized by the degradation of joint cartilage and inflammation. Zinc is crucial to the development of healthy cells, including cartilage, and copper keeps cartilage in balance and improves the immune response. If these elements are imbalanced, then symptoms of osteoarthritis may worsen, and studies have revealed that people with osteoarthritis exhibit increased levels of copper, which is the active factor in inflammation and cartilage breakdown. In osteoarthritis patients, the level of zinc is decreased, yet it plays an important role in bone and cartilage formation. Zinc and copper are interrelated because zinc has antioxidant properties, while copper might have a detrimental effect on cell injury. More investigations must be conducted on the therapeutic aspects of these processes and on how to improve the treatment of osteoarthritis. Knowledge of these relationships could allow for enhanced diagnosis, proper treatment, and therapy for people with osteoarthritis, hence enhancing quality of life.
- 28 April 2025
- Published by Springer Nature in Biological Trace Element Research
- Vol. 203 (12) , 6206-6212
Is There Any Role of Zinc and Copper in Severity and Progression of Osteoarthritis? A Review
Osteoarthritis (OA) is one of the most prevalent chronic diseases of the aging population, with an incidence of more than 250 million affected people and annual treatment costs exceeding $80 billion. Osteoarthritis involves pain, stiffness, reduced mobility, and swelling of the joints due to cartilage wear and tear and inflammation, which results in a broad system affecting the joints. This review focuses on the relationship between zinc and copper and the effects of these minerals on osteoarthritis. Osteoarthritis is a degenerative disease that currently affects millions of people and is characterized by the degradation of joint cartilage and inflammation. Zinc is crucial to the development of healthy cells, including cartilage, and copper keeps cartilage in balance and improves the immune response. If these elements are imbalanced, then symptoms of osteoarthritis may worsen, and studies have revealed that people with osteoarthritis exhibit increased levels of copper, which is the active factor in inflammation and cartilage breakdown. In osteoarthritis patients, the level of zinc is decreased, yet it plays an important role in bone and cartilage formation. Zinc and copper are interrelated because zinc has antioxidant properties, while copper might have a detrimental effect on cell injury. More investigations must be conducted on the therapeutic aspects of these processes and on how to improve the treatment of osteoarthritis. Knowledge of these relationships could allow for enhanced diagnosis, proper treatment, and therapy for people with osteoarthritis, hence enhancing quality of life.